Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Spotlight on angiotensin II blocker/ACE inhibitor combination therapy

Oct. 10, 1997

Mutual recognition approval obtained for Astra's angiotensin II blocker

Oct. 9, 1997

Flocor pivotal trial supported by FDA grant

Oct. 9, 1997

Mylan receives FDA approval for generic verapamil

Oct. 9, 1997

Octreotide assessed in treatment of restenosis in VERAS study

Oct. 9, 1997

GenVec/Parke-Davis collaboration focusing on angiogenic products

Oct. 8, 1997

New antiarrhythmics from American Cyanamid

Oct. 8, 1997

Key cardiovascular gene therapy patent awarded to CardioGene Therapeutics

Oct. 8, 1997

Hoechst describes Na+/H+-exchange inhibitors for ischemic disorders

Oct. 8, 1997

New discovery enhances feasibility of cardiovascular gene therapy

Oct. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...